Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001692830-16-000001
Filing Date
2016-12-29
Accepted
2016-12-28 17:50:50
Documents
1
Effectiveness Date
2016-12-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7027
  Complete submission text file 0001692830-16-000001.txt   8050
Mailing Address 1337 3RD AVENUE SAN FRANCISCO CA 94122
Business Address 1337 3RD AVENUE SAN FRANCISCO CA 94122 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-277219 | Film No.: 162073236